![Sara Bonstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sara Bonstein
Directeur Financier/CFO chez
INSMED INCORPORATED
Fortune : 7 M $ au 30/06/2026
Profil
Sara M.
Bonstein is currently Chairman at Xilio Therapeutics, Inc. since 2026, Independent Director at Latigo Biotherapeutics, Inc. since 2026, and Chief Financial Officer at Insmed, Inc. since 2020.
Former roles include Independent Director at scPharmaceuticals, Inc. from 2020 to 2025, Chief Operating & Financial Officer, Secretary at OncoSec Medical, Inc. from 2018 to 2020, CFO, Secretary, Treasurer & Executive VP at Advaxis, Inc. from 2014 to 2018, Director-Development Finance at ImClone LLC from 2004 to 2014, and Finance Director at Eli Lilly & Co. Education includes undergraduate studies at The College of New Jersey and an MBA from Rider University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INSMED INCORPORATED 0,03 % | 03/06/2026 | 69 082 ( 0,03 % ) | 7 M $ | 30/06/2026 |
| 11/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Sara Bonstein
| Sociétés | Poste | Début |
|---|---|---|
| INSMED INCORPORATED | Directeur Financier/CFO | 31/01/2020 |
| XILIO THERAPEUTICS, INC. | Président | 08/01/2026 |
Latigo Biotherapeutics, Inc.
 Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company that develops non-opioid pain medicines | Directeur/Membre du Conseil | 01/04/2026 |
Anciens postes connus de Sara Bonstein
| Sociétés | Poste | Fin |
|---|---|---|
| SCPHARMACEUTICALS INC. | Directeur/Membre du Conseil | 07/10/2025 |
| ONCOSEC MEDICAL INCORPORATED | Directeur Financier/CFO | 30/01/2020 |
| AYALA PHARMACEUTICALS, INC. | Directeur Financier/CFO | 30/04/2018 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Corporate Officer/Principal | 01/02/2014 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Formation de Sara Bonstein
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
59
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Insmed, Inc.
 Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
OncoSec Medical, Inc.
 OncoSec Medical, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel immunotherapeutic products for immuno-oncology treatment | Health Technology |
The College of New Jersey
 The College of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer and infectious diseases | Health Technology |
Rider University
 Rider University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
scPharmaceuticals, Inc.
 scPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products to the cardiovascular and infectious diseases | Health Technology |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company that develops non-opioid pain medicines | Health Technology |
